Objectives: To investigate the landscape of cognitive impairment (CI) screening for adults with age-related hearing loss (ARHL) among otolaryngologists and audiologists.
of 2010 mandates that Medicare recipients undergo yearly cognitive screening during their annual WellCare visit, but does not specify choice and use of screening tools. 3, 4 In contrast, in 2013, the United
States Preventative Services Task Force (USPTF) found no strong evidence for generalized CI screening of the public, as screening was not found to significantly increase quality of life or disease progression;
however, it did find evidence for CI screening for patients who report subjective memory loss or exhibit risk factors for CI. 4, 5 Additionally, it called for an increase in identification and understanding of potential risk factors for CI.
Disabling hearing loss (HL) affects 432 million adults worldwide and approximately two-thirds of adults older than 70 years. 6 In the last decade, mounting research has indicated an independent and linear relationship between CI and HL, and a recent meta-analysis of 36 epidemiologic studies demonstrated that age-related hearing loss (ARHL) was significantly associated with decline in all main cognitive domains and with increased risk for CI and incident dementia. [7] [8] [9] Furthermore, the 2017 Lancet Commission on Dementia Prevention, Intervention and Care identified HL as the highest contributing modifiable risk factor for dementia. 2 With HL now established as a strong risk factor for CI, investigation has begun on how to modify that risk. Several studies have measured and are measuring the effect of aural rehabilitation and cochlear implantation on cognition in patients with ARHL, with promising results. [10] [11] [12] [13] [14] [15] [16] The future of continued research on the modification of CI in those with ARHL may depend on the early identification of those most at risk, and (MMSE); however, dozens more screening tools have been used in the general population. [17] [18] [19] [20] Additionally, work is being put into the validation of CI screening tools made specifically for patients with ARHL, such as the HI-MOCA. 21 Still, there have been no published guidelines to assist providers in determining the appropriate clinical setting or presentation of a patient with ARHL that should prompt CI screening.
Thus, the objective of this study was to understand the current practices and perceptions of audiologists and otolaryngologists on the screening of CI for adults with ARHL. We hypothesized that the current rate of CI screening in this population would likely be low, but vary among provider profession, experience, time, and knowledge of current literature.
Additionally, we hypothesized that there would be no consensus on the patient characteristics or presentations that would prompt screening. Secondarily, we aimed to understand the current practices and perceptions of referral for CI screening, to identify gaps in guideline adherence.
| MATERIALS AND METHODS

| Survey design
We developed an online survey to assess the practices of screening for CI in adults with ARHL among providers who regularly see adults with ARHL. The survey was distributed to three faculty and three resident members of the Otolaryngology Department at Emory University to test understanding of the content and intent of survey questions.
The final version was a 15-question web-based survey maintained by Google Forms (Google LLC, Mountain View, California). The survey contained questions on demographics, screening and referral habits, and screening and referral knowledge (Supporting Information A).
Three questions assessed the screening and referral habits of all respondents. Providers were asked if they ever carry out cognitive screening or ever refer patients in their practice for cognitive screening. Providers who responded that they did perform screening or did provide referral were then directed to a set of three questions regarding patient characteristics that would their prompt screening or referral. Additionally, providers were asked to which type of specialist they would refer their patients for cognitive screening.
Institutional Review Board. No incentives were provided for survey completion.
| Statistical analysis
Responses were tabulated by Google Forms and transferred to Excel.
Summary statistics (frequency and percentages) were developed from providers' survey responses. To identify provider characteristics and perceptions significantly associated with screening and referral, chisquare and Fisher's exact tests were used for non-ordinal variables,
and Cochran-Mantel-Haenszel's test was used for ordinal variables.
Pairwise comparisons were done for any variables where P < .15 in the overall categorical analysis. Additionally, any variables with P < .15 from these univariate analyses were considered for multivariable logistic regression.
Two multiple logistic regression models were fit, one for screen and one for refer. "Profession," "time allotted for new patient visit,"
"new patients with ARHL seen weekly," and "degree of HL as a factor for screening" were included a priori in the screening logistic regression model. "Profession," "new patients with ARHL seen weekly," and "degree of HL as a factor for referral" were included a priori in the referral logistic regression model. Only a priori variables and variables with P < .15 from univariate regression were included in the final multivariable logistic regression models in to generate a model that had potential to capture all relevant factors.
All analyses were conducted in SAS 9.4 TS Level 1 M5 (SAS Institute Inc, Cary, North Carolina). An alpha level of .05 was utilized to determine statistical significance for the univariate analyses and multivariable logistic regression.
| RESULTS
Of the 70 respondents, 66 were providers who see adult patients with HL regularly. The four excluded participants identified as head and neck surgeons or pediatric otolaryngologists.
| Study demographics
The study demographics are listed in Table 1 
| Practice patterns
Just under a quarter (21.21%, n = 14) of providers reported screening for CI, whereas nearly two-thirds (63.63%, n = 42) reported referring for CI (P < .001) ( Table 2 ). Profession was the only factor significantly associated with screening. Providers in the "other" category, three
SLPs, were much more likely to screen (100%, n = 3) than audiologists (21.74%, n = 5, P = .0215), neurotologists (15.38%, n = 4, P = .0096), and general otolaryngologists (14.29%, n = 2, P = .0147). The association between screening and the numbers of visits weekly for a new patient with ARHL and the time allotted for a visit for a new patient with ARHL approached significance (P = .0558 and P = .068, respectively). Providers seeing <10 patients with ARHL weekly were more likely to screen (44.44%, n = 4) than those seeing 10 to 20 (24%, n = 6), 20 to 30 (13.33%, n = 2) and >30 patients (11.76%, n = 2).
Additionally, providers allotting more than 1 hour for a visit were more likely to screen (46.15%, n = 6) than those allotting <30 minutes (15%, n = 3) or 30 minutes to 1 hour (15.15%, n = 5). Year of training completion and practice type were not significantly associated with cognitive screening.
T A B L E 1 Study demographics, total n = 66 Profession was also significantly associated with referring for CI evaluation. General otolaryngologists were significantly less likely to refer for CI than neurotologists (28.57%, n = 4 vs 80.77%, n = 21, P = .002), and though not statistically significant, general otolaryngologists were also less likely to refer than audiologists and SLPs (60.87%, n = 14, P = .0911 and 100%, n = 3, P = .0515, respectively). Year of training completion, practice type, time allotted for a new patient visit for ARHL and number of new patients with ARHL seen weekly were not significantly associated with referral.
| Knowledge and perceptions
Among providers who screen for CI, there was no consensus on which patient age group should prompt reflexive CI screening (Table 3) ; approximately one-third would screen patients >60 years (29%, n = 4), one-third would screen patients >70 years (36%, n = 5) and a third did not believe that age was a factor to be considered (36%, n = 5). There was similarly no consensus among providers who do not routinely screen as to what age should prompt screening, and over a third of these providers (40.4%, n = 21) believed that age is not a factor to be considered for screening. Likewise, there was no consensus among providers who do and do not screen as to which patient degree of HL should prompt CI screening, though nearly half of providers (43.94%, n = 29) believe that degree of HL should not be a factor. The majority of providers (84.85%, n = 56) would not screen a new patient with HL for CI or even patients presenting with a symptom of memory loss (69.7% n = 46). Interestingly, nearly three-quarters of providers (72.73%, n = 48) would not screen a patient presenting with both HL and a symptom such as memory loss.
Among providers who refer patients for CI evaluation, there was no consensus on which patient age group or degree of HL should prompt referral (Table 3) . Similarly, there was no consensus regarding the role of age or degree of HL in CI referral among providers who do not regularly refer. Over half of all providers would not consider age There was no variable found to be significantly associated with screening in the multivariable logistic regression model after adjustment (Figure 1 ). There was no consensus on the type of specialists to which a referral for CI evaluation be made, however, more respondents would refer patients for CI evaluation to neurologists (35%, n = 23) and internists (23%, n = 15) than gerontologists, psychiatrists and neuropsychologists (Figure 2 ).
F I G U R E 1 Distribution of screening test choices
F I G U R E
| DISCUSSION
HL has been identified as a modifiable risk factor for CI, and audiologists and otolaryngologists who regularly see adults with ARHL should be aware of this relationship and its implications for practice. This group of practitioners are uniquely positioned to evaluate a high-risk community of patients for CI and ensure that they are receiving appropriate care by way of referral. Unsurprisingly, however, the majority of respondents to this survey reported not screening for CI in their practices. We predicted that screening rates would be low, because of the relatively recently established relationship between CI and HL, the previously vague recommendations for CI screening in the community, and the time constraints of specialized practices.
Though we anticipated that audiologists might screen more than neurotologists or general otolaryngologists because of the nature of their training and generally longer length appointment times, we found that SLPs working with patients who will receive cochlear implants screen the most. In the free response sections, these three providers, reported screening all patients who are undergoing evaluation for cochlear implantation. Generalizability of these results should be cautioned because of the small number of SLPs, however. Further inquiry should be made into the specific techniques and indications for CI screening among this group for guideline development.
Unexpectedly, we found that seeing fewer than 10 patients with ARHL weekly was associated with a higher rate of screening than seeing more than 10, although this association was not statistically significant, and the relationship became even weaker on multivariable logistic regression. Furthermore, we found that respondents with greater than 1-hour time slots for a new patient visit for ARHL were more likely to screen than respondents with shorter time slots, though again this relationship was not statistically significant. Together, these trends may suggest that providers who have more time and see less patients may be more apt to screen; however, again, generalizability should be cautioned and these trends should be further investigated.
Still, prior to the widespread dissemination of literature surrounding primary care identification of CI, barriers to diagnosis in the primary care setting included limited time, lack of routine, and physician attitudes. 22 Despite the low rate of reported CI screening, it is reassuring that a larger proportion of respondents reported referring patients for CI evaluation. This calls into question the views of respondents on the role they play in caring for these patients; providers may feel that screening for CI is out of the scope of their practice or that they are ill-equipped to perform screening, as previously suggested. 22 The more specialized providers, neurotologists, SLPs and audiologists, referred at higher rates than general otolaryngologists. Though small sample sizes, this suggests that these providers may see more patients who warrant referral or highlights the relative ease of referral to CI specialists within an academic center, among several possible explanations. What is alarming, however, is that only half of respondents would refer a new patient presenting with a neurologic symptom, like memory loss, for CI evaluation, and under half would refer a new patient presenting with both a neurologic symptom, like memory loss, and HL. This suggests that although many providers recognize the benefit of specialized evaluation for CI, still many may not appreciate the value. Early detection of CI can lead patients and families to prepare for risks associated with CI, seek out education and support groups, enlist in research studies, begin medications to reduce symptoms, and obtain more appropriate medical care for comorbidities. 3 Furthermore, literature from the primary care setting suggests that barriers to appropriate diagnosis (in this instance, referral for CI evaluation after a complaint of memory loss) may be related to lack of knowledge, concern for potential negative impact on families and patients, or low prioritization of CI recognition. 23 In addition to the limited consensus on patient presentations that should prompt screening and referral for CI, there was no consensus on the best screening assessment to use. A plethora of research has been conducted on the relationship between CI and HL using a variety of CI screening and diagnostic tools, yet only one study to our knowledge has been conducted to attempt establishment of validation of an instrument designed specifically for patients with HL. 21 Though the audiology literature has suggested that the MoCA may be the best CI screening tool to use for adults with ARHL, mounting evidence points toward the need for development of tools specifically validated for this population. 17, 19, [24] [25] [26] The lack of a validated screening tool may also explain the low rates of screening, even for patients presenting with a complaint of memory loss.
Finally, practitioners have a wide base of referral for CI evaluation, including internists, neurologists, psychologists, gerontologists and neuropsychologists, and there was no single group to which respondents of this survey were likeliest to refer patients. It is therefore important for this group of providers to recognize that they all may be referred patients with ARHL and should have tools specifically designed for them. Furthermore, audiology and otolaryngology communities may be benefit from improved collaboration and communication with these specialists in to establish appropriate and consistent referral patterns.
There are several limitations with this study. First, this survey was designed to determine practice patterns and perceptions, but the methodology likely results in best practice patterns, a proxy for what actually occurs in practice, as currently there is no objective tool (like the medical record system) that could be used to understand what providers are actually doing. Therefore, the results of this survey are estimates, and perhaps overestimates, of reality. Second, we estimate the response rate to be~12%. The survey was sent by email LIST-SERV to one national group (ANS/AOS) and two Georgia state groups (GAA and GSO), for which the membership to the email LISTSERV was known. However, the number of potential survey recipients of ASHA is unknown, because the survey was posted on a web forum, rather than sent by email. This is problematic in three ways: Georgia state practices may be over-represented because of the imbalance between national and statewide recipients, audiologists may be under-represented because of the lack of automatic receival of the survey, and the response rate may be a slight over-estimation.
Additionally, we hoped that by choosing representative groups from general otolaryngology (the GSO) and audiology (the GAA and two
SIGs from ASHA) we would obtain generalizability results; however, caution must be used in generalizing to the broader community because of this response rate. Additionally, the distribution technique may have led to sampling bias, in which providers with a special interest in CI chose to respond to the survey at higher rates than those without an interest. Finally, the survey was not designed for respondents to justify their practices, therefore we did not collect data on why providers do not screen or refer. Given the unexpectedly low rates of reported referral, this should be a target for future investigation.
| CONCLUSION
The practice of screening for CI and referring for CI evaluation for adults with ARHL among audiologists and otolaryngologists is not routine. There is no consensus on which age or degree of HL should prompt screening. Neither is there adequate screening and referral for patients who present with a neurologic complaint, such as memory loss. Audiologists and otolaryngologists are uniquely positioned to improve the care of an adult population at high risk for modifiable CI and dementia, and should therefore, work toward improved knowledge of the relationship between HL, age and CI. Future research should focus on the development of simple, time efficient CI screening tools and guidelines surrounding their use for this particular patient population.
